ZURICH (Reuters) - Novartis's push into oncology and liver disease, two of its treatment priorities, advanced on Monday as the Swiss drugmaker won... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/HaWHDTZM12A/us-novartis-allergan-idINKBN17K0TE
Drug firm Torrent Pharmaceuticals today said it has entered into pacts with Swiss pharma major Novartis AG to acquire certain generic drugs. ...http://www.dnaindia.com/money/report-torrent-pharma-to-buy-certain-generic-drugs-from-noavrtis-2396788
Greece's justice minister today said Swiss pharmaceutical giant Novartis had likely bribed "thousands" of doctors and civil servants to promote its... ...http://www.dnaindia.com/health/report-swiss-giant-novartis-likely-bribed-thousands-in-greece-2386193
Posted by Equitymaster After opening the day marginally lower, share markets in India have remained range bound and are trading marginally below... ...http://www.equitymaster.com/tm/tm.asp?date=3/31/2017&title=Sensex-Remains-Range-bound-IT-Stocks-Drag
A new leukemia treatment from Novartis for children and young adults will get priority review from the U.S. Food and Drug Administration (FDA),... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/lZokku8ccD4/us-novartis-cancer-filing-idINKBN1710II
MP-NAT however test execution was...